Circulating concentrations of B-type natriuretic peptide (BNP) and the N-terminal ... In stable CAD, the risk associated with BNP and NT-proBNP levels is proportional to the magnitude of BNP ...
Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...
The initial primary use of measuring b-type natriuretic peptide (BNP) is to determine the etiology of dyspnea in patients presenting to the emergency department. If the BNP level is significantly ...
The initial primary use of measuring b-type natriuretic peptide (BNP) is to determine the etiology of dyspnea in patients presenting to the emergency department. If the BNP level is significantly ...
It has been shown that natriuretic peptide levels are higher following transplantation – and never return to normal. Although some of the elevation is probably a response to the trauma of ...
At the time, he was pumping 10 liters per minute. He had a proBNP natriuretic peptide level over 10,000 and an ejection fraction of 39%. Later, he was found to have an abdominal arteriovenous ...
WBZ_4 did not affect levels of brain natriuretic peptide — a marker of myocardial hypertrophy and cardiac impairment — or affect left-ventricular cardiac function. JNK1/2 activation was ...
At the time, he was pumping 10 litres per minute. He had a proBNP natriuretic peptide level over 10,000 and an ejection fraction of 39%. Later, he was found to have an abdominal arteriovenous ...